loadpatents
Patent applications and USPTO patent grants for AETAS PHARMA CO., LTD..The latest application filed is for "renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative".
Patent | Date |
---|---|
Renal Dysfunction Improving Drug Comprising Optical Isomer Of 1,4-benzothiazepine-1-oxide Derivative App 20200390782 - Kaneko; Noboru | 2020-12-17 |
Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same Grant 10,071,996 - Kaneko September 11, 2 | 2018-09-11 |
Optical Isomer Of 1,4-benzothiazepine-1-oxide Derivative, And Pharmaceutical Composition Prepared Using Same App 20170247362 - Kaneko; Noboru | 2017-08-31 |
Diphenylmethyl piperazine derivative and pharmaceutical composition using same Grant 9,073,861 - Kaneko July 7, 2 | 2015-07-07 |
Diphenylmethyl Piperazine Derivative And Pharmaceutical Composition Using Same App 20140296253 - Kaneko; Noboru | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.